Evaluation of Pharmacokinetic Interaction of Cilostazol with Metoclopramide after Oral Administration in Human.

Kaukab, Iram; Hussain Shah, Syed Nisar; Kharaba, Zelal; Murtaza, Ghulam; Saad, Abubaker Ali; Ahmad, Shakeel

Kaukab, Iram; Hussain Shah, Syed Nisar; Kharaba, Zelal; Murtaza, Ghulam; Saad, Abubaker Ali; Ahmad, Shakeel.

Afiliación

Kaukab I; Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan.
Hussain Shah SN; Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan.
Kharaba Z; Department of Clinical Pharmacy, Al-Ain University, Abu Dhabi, United Arab Emirates.
Murtaza G; Honorary Associate Lecturer, Faculty of Medical Sciences, Newcastle university, Newcastle Upon Tyne, United Kingdom.
Saad AA; Department of Pharmacy, COMSATS University Islamabad, Lahore Campus, Lahore 54000, Pakistan.
Ahmad S; Department of Cardiology, Chaudhary Pervaiz Elahi Institute of Cardiology, Multan, Pakistan.

Curr Drug Metab ; 20(11): 924-928, 2019.

Article en En | MEDLINE | ID: mdl-31702486

Asunto(s)

Cilostazol/farmacocinética; Metoclopramida/farmacocinética; Administración Oral; Adulto; Cilostazol/farmacología; Estudios Cruzados; Interacciones Farmacológicas; Humanos; Masculino; Metoclopramida/farmacología

Palabras clave

CYP substrate; Cilostazol; interaction; metabolism; metoclopramide; pharmacokinetics.

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cilostazol / Metoclopramida Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Humans / Male Idioma: En Revista: Curr Drug Metab Asunto de la revista: METABOLISMO / QUIMICA Año: 2019 Tipo del documento: Article País de afiliación: Pakistán Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google